Blood‐Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major Depression: Indication for Disease Subsets

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Alzheimer Disease and Associated Disorders

• Publication date

  1997-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00002093-199706000-00004PMID 9194954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Postmortal diffusion of plasma albumin in rat brain

  2005cited by this paper
• The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease

  2004cited by this paper
• The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid

  2004cited by this paper
• Differentiation of the humoral immune response in inflammatory diseases of the central nervous system

  2004cited by this paper
• Perivascular deposits of serum proteins in cerebral cortex in vascular dementia

  2004cited by this paper
• Central Nervous System IgG Synthesis Rates in Alzheimer Disease: Possible Differences in Early‐Onset and Late‐Onset Subgroups

  1994cited by this paper
• Altered blood‐brain‐barrier function in Alzheimer's disease?

  1994cited by this paper
• Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression.

  1994cited by this paper
• Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease.

  1993cited by this paper
• CSF transthyretin in patients with depression.

  1993cited by this paper
• [Neuropathologic, immunologic and psychobiological aspects of Alzheimer's dementia].

  1993cited by this paper
• Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view.

  1992cited by this paper
• Antibody-mediated clearance of alphavirus infection from neurons.

  1991cited by this paper
• Leakage and neuronal uptake of serum protein in aged and Alzheimer brains. A postmortem phenomenon with antemortem etiology.

  1991cited by this paper
• Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review.

  1990cited by this paper
• Elevated CSF protein in male patients with depression.

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

  1989cited by this paper
• Cerebrospinal Fluid Parameters in Healthy Volunteers During Serial Lumbar Punctures

  1989cited by this paper
• Regional cerebral glucose transport and utilization in Alzheimer's disease

  1989cited by this paper
• Protein gradients in the cerebrospinal fluid and the calculation of intracerebral IgG synthesis.

  1988cited by this paper
• Effect of aging on the blood-brain barrier.

  1988cited by this paper
• Examination of Blood — Brain Barrier Permeability in Dementia of the Alzheimer Type with [68Ga]EDTA and Positron Emission Tomography

  1987cited by this paper
• High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G.

  1987cited by this paper
• CSF and serum concentrations of albumin and IgG in Alzheimer's disease.

  1987cited by this paper
• Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man.

  1987cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper
• Blood-brain barrier in Alzheimer dementia and in non-demented elderly

  1987cited by this paper
• Intraneuronal IgG in the central nervous system

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey

  1986cited by this paper
• An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease.

  1986cited by this paper
• The Blood-Brain Barrier in Alzheimer's Disease

  1986cited by this paper
• The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid.

  1985cited by this paper
• CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.

  1985cited by this paper
• On causative theories in Alzheimer's disease.

  1985cited by this paper
• The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.

  1984cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper
• Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

  1983cited by this paper
• Integrity of blood-brain barrier to peroxidase in senescent mice.

  1983cited by this paper
• Variation in immunoglobulin G and albumin concentrations during lumbar CSF removal

  1982cited by this paper
• Immunological Indices in the Cerebrospinal Fluid of Patients with Presenile Dementia of the Alzheimer Type

  1982cited by this paper
• Evidence for Blood‐Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT)

  1982cited by this paper
• IMMUNOHISTOCHEMICAL STAINING OF SENILE PLAQUES

  1982cited by this paper
• Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration.

  1981cited by this paper
• Serum Immunoglobulins and Cognitive Status in the Elderly: 1. A Population Study

  1980cited by this paper
• Pathological verification of ischemic score in differentiation of dementias

  1980cited by this paper
• Blood-brain barrier permeability in senescent rats.

  1979cited by this paper
• Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia).

  1979cited by this paper
• Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid. Separate areas of reference.

  1978cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

  1977cited by this paper
• Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques

  1976cited by this paper
• The incidence of cerebral amyloid angiopathy in Alzheimer's disease

  1975cited by this paper
• Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique

  1975cited by this paper
• JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN

  1969cited by this paper
• Observations on the brains of demented old people.

  1968cited by this paper
• Factors influencing the concentration gradient of protein in cerebrospinal fluid.

  1958cited by this paper

• Revisiting a hypothesis: the neurovascular unit as a link between major depression and neurodegenerative disorders

  2024cites this paper
• Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers

  2023cites this paper
• Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease

  2023cites this paper
• Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease

  2022cites this paper
• Journal Pre-proof Neuroinflammatory biomarkers in the cerebrospinal fluid from 106 patients with recent onset depression compared to 106 individually matched healthy controls

  2022cites this paper
• Pb Induces MCP-1 in the Choroid Plexus

  2022cites this paper
• Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases

  2022cites this paper
• Neuroinflammatory Biomarkers in Cerebrospinal Fluid From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects.

  2022cites this paper
• Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease

  2021cites this paper
• Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact

  2021cites this paper
• Serum albumin and beta-amyloid deposition in the human brain

  2020cites this paper
• Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics

  2019cites this paper
• Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis

  2018cites this paper
• Turning Point towards Blood Biomarker-Guided Targeted Therapy for Precision Medicine in Alzheimer's Disease

  2018cites this paper
• CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.

  2017cites this paper
• Anti-Inflammatory and Immune-Modulatory Therapeutic Approaches in Major Depression

  2016cites this paper
• Importance of P-gp PET Imaging in Pharmacology.

  2016cites this paper
• The choroid plexus-cerebrospinal fluid interface in Alzheimer's disease: more than just a barrier

  2016cites this paper
• Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer’s Disease

  2016cites this paper
• Integrating neuroimmune systems in the neurobiology of depression

  2016cites this paper
• iTRAQ technology-based identification of human peripheral serum proteins associated with depression.

  2016influential citation
• Cerebrovascular and Blood-Brain Barrier Compromise: A Mechanistic Link between Vascular Disease and Alzheimer’s Disease Subtypes of Neurocognitive Disorders

  2015cites this paper
• Myeloid cells in Alzheimer's disease: culprits, victims or innocent bystanders?

  2015cites this paper
• Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression

  2014cites this paper
• Immunology of Major Depression

  2014cites this paper
• The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings

  2013cites this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cites this paper
• Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease.

  2012cites this paper
• Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.

  2012cites this paper
• Biomarkers for major depression and its delineation from neurodegenerative disorders.

  2011cites this paper
• Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression

  2011cites this paper
• Blood-Cerebrospinal Fluid Barrier Permeability in Alzheimer's Disease

  2011cites this paper
• The guarded brain: the role of P-glycoprotein at the blood-brain barrier in major psychiatric disorders and antidepressant treatment

  2011influential citation
• Mood Disorders Are Glial Disorders: Evidence from In Vivo Studies

  2010cites this paper
• Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.

  2010cites this paper
• Is there a CSF biomarker profile related to depression in elderly women?

  2010cites this paper
• 11C-verapamil to assess P-gp function in human brain during aging, depression and neurodegenerative disease.

  2010cites this paper
• Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood—brain barrier: an experimental PET study in rats

  2010cites this paper
• Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

  2009cites this paper
• Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study.

  2009cites this paper
• Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging

  2009influential citation
• Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier.

  2009cites this paper
• Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease

  2009cites this paper
• Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease

  2009cites this paper
• Liberación intracerebroventricular rápida de Cu-DOTA-etanercept después de la administración periférica demostrada con imágenes PET.

  2009cites this paper
• Serum markers support disease-specific glial pathology in major depression.

  2008cites this paper
• Identification of novel brain biomarkers.

  2006cites this paper
• Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

  2006cites this paper
• Serum inflammatory proteins and cognitive decline in older persons

  2005cites this paper
• The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder

  2004cites this paper
• Is the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia?

  2003cites this paper
• S100B is increased in mood disorders and may be reduced by antidepressive treatment

  2002cites this paper
• Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier

  2002cites this paper
• The relationship of depression and stressors to immunological assays: a meta-analytic review.

  2001cites this paper
• Morphological Ground of Formation of the Brain Choroid Plexus Blood-Cerebrospinal Fluid Barrier in Human Prenatal Ontogenesis

  2001cites this paper
• Biologische Untersuchungen in der Differentialdiagnostik kognitiver und depressiver Störungen im Alter

  2001cites this paper
• Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.

  2001cites this paper
• Does the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration?

  2000cites this paper
• Early Diagnosis of Alzheimer’s Disease

  2000cites this paper
• Increased serum arginase activity in depressed patients.

  2000cites this paper
• Peripheral Markers of Alzheimer’s

  2000cites this paper
• Does The Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration? (44509)

  2000cites this paper
• Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.

  1999cites this paper
• Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

  1999cites this paper